Рибревант
Active substance: amivantamab
концентрат для приготовления раствора для инфузий, 350 мг, 7 мл (original in Russian, GRLS)
RussiaActive
Marketing holder: ООО "Джонсон & Джонсон"
Verified 2026-10-09 · GRLS (Russian state register)
Analogues in other countries- Source: GRLS (Russian state register)
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| US 5 |
|
| EU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-dbb9-770c-a8f2-c525bdfd6071;count=1 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-f65e-7be4-84d3-01dcb734e8b3;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- ЛП-№(014025)-(РГ-RU)
- Registration status
- Active
- Dispensing
- Prescription only
- Release forms
- концентрат для приготовления раствора для инфузий, 350 мг, 7 мл - флаконы - пачки картонные - По рецепту; (original in Russian, GRLS)
Sources
- product · GRLS (Russian state register) · ЛП-№(014025)-(РГ-RU) · Verified 2026-10-09
- registration_status · GRLS (Russian state register) · ЛП-№(014025)-(РГ-RU) · Verified 2026-10-09
- ingredients.0 · GRLS (Russian state register) · ЛП-№(014025)-(РГ-RU) · Verified 2026-10-09